Inventor · disambiguated record
Frithjof Sczesny
Also filed as: SCZESNY FRITHJOF
3 granted patents·16 pending applications·3 citations·filing 2006–2025
58Inventor score
Top patents by PatentIndex Score
19 records- 0178US9198871B2Delayed release pancreatin compositionsSHLIEOUT GEORGE·Filed 2006·Granted Dec 1, 2015·3 cites·32 claims
- 0274US2024424070A1Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2024·Application pending·0 cites
- 0370US2025345405A1Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2025·Application pending·0 cites
- 0468US2021353722A1Controlled release pharmaceutical compositions for acid-labile drugsAbbVie Pharmaceuticals GmbH·Filed 2021·Application pending·0 cites
- 0566US2019247473A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2019·Application pending·0 cites
- 0666US2022211825A1Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2022·Application pending·0 cites
- 0766US2021060142A1Controlled release pharmaceutical compositions for acid-labile drugsAbbVie Pharmaceuticals GmbH·Filed 2020·Application pending·0 cites
- 0866US2024148660A1Process for the manufacture and use of pancreatin micropellet coresAbbVie Pharmaceuticals GmbH·Filed 2024·Application pending·0 cites
- 0961US2014065232A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2013·Application pending·0 cites
- 1059US11278603B2Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2017·Granted Mar 22, 2022·0 cites·35 claims
- 1159US2025152683A1Processes for producing compositions with improved safety profile having lipase activity and compositions suitable for pharmaceutical useABBVIE INC·Filed 2025·Application pending·0 cites
- 1258US2022183988A1Process for the manufacture and use of pancreatin micropellet coresAbbVie Pharmaceuticals GmbH·Filed 2022·Application pending·0 cites
- 1356US11266607B2Process for the manufacture and use of pancreatin micropellet coresSHLIEOUT GEORGE·Filed 2006·Granted Mar 8, 2022·0 cites·101 claims
- 1456US2016263201A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2016·Application pending·0 cites
- 1555US2024226249A9Controlled release pharmaceutical compositions for acid-labile drugsAbbVie Pharmaceuticals GmbH·Filed 2023·Application pending·0 cites
- 1655US2016095906A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2015·Application pending·0 cites
- 1750US2019201502A1Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2019·Application pending·0 cites
- 1848US2019151425A1Processes for producing compositions with improved safety profile having lipase activity and compositions suitable for pharmaceutical useSHLIEOUT GEORGE·Filed 2019·Application pending·0 cites
- 1939US2016120964A1Processes for producing compositions with improved safety profile having lipase activity and compositions suitable for pharmaceutical useSHLIEOUT GEORGE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frithjof Sczesny files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →